Biogen (BIIB) gain as Eli Lilly's AD drug delayed by FDA

March 8, 2024 6:51 AM EST Send to a Friend

Biogen (NASDAQ: BIIB) gains as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Biogen (BIIB) gain as Eli Lilly's AD drug delayed by FDA

Member Login

Free News Feed